| Officer | Age | In this role | Joined | Source |
|---|---|---|---|---|
|
Sean A. McCarthy
Also a director
Chief Executive Officer and Chairman of the Board
|
59 | Not stated | Not stated | |
|
Christopher (Chris) W. Ogden
Senior Vice President, Chief Financial Officer
|
42 |
Since 2024
2 years
|
2021 | |
|
Marcia P. Belvin
Senior Vice President, Chief Scientific Officer
|
59 |
Since 2022
4 years
|
2018 | |
|
Yu-Waye (Wayne) Chu
Senior Vice President, Chief Medical Officer
|
58 |
Since 2023
3 years
|
2023 | |
|
Rachael Lester
Senior Vice President, Chief Business Officer
|
48 |
Since 2025
1 year
|
2025 | |
|
Alejandra Carvajal
Chief Legal Officer
Title from the Form 3 dated Aug 3, 2026
|
Not stated | Not stated | Not stated |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 30, 2026 · updated by the 8-K of Jul 27, 2026
| Director | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|
|
James R. Meyers
|
2018
8 years
|
Independent | None stated | Sangamo Therapeutics, Inc. | $139,514 | |
|
Halley Gilbert
|
2020
6 years
|
Independent |
Audit
|
Arcutis Biotherapeutics, Inc., Vaxcyte, Inc. | $143,014 | |
|
Alan Ashworth, Ph.D.
|
2021
5 years
|
Independent |
Nominating and Corporate Governance
|
None stated | $131,514 | |
|
Elaine V. Jones, Ph.D.
|
Not stated | Independent |
Compensation
Nominating and Corporate Governance
|
None stated | $137,514 | |
|
Sean A. McCarthy, D. Phil.
|
Not stated | Not independent | None stated | None stated | Not stated | |
|
Mani Mohindru, Ph.D.
|
Not stated | Independent |
Audit
|
None stated | $136,514 | |
|
Matthew P. Young
|
Not stated | Independent | None stated | None stated | $167,514 | |
|
Zhen Su, M.D., M.B.A.
|
Not stated | Independent |
Compensation
|
None stated | Not stated | |
|
Charles Fuchs
Joined Jul 24, 2026
|
- | - | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 30, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...